Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-01 Sale |
2023-05-03 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $805.33 | $80,533 | 18,947 (Direct) |
View |
| 2023-04-21 Sale |
2023-04-24 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,070 | $798.42 | $2,451,149 | 12,409 (Indirect Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $819.31 | $81,931 | 19,047 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $818.8 | $900,680 | 25,391 (Indirect Direct) |
View |
| 2023-03-27 Sale |
2023-03-29 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,190 | $823.2 | $979,605 | 52,509 (Indirect Direct) |
View |
| 2023-03-24 Sale |
2023-03-27 4:43 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $818 | $1,014,320 | 3,727 (Direct) |
View |
| 2023-03-23 Sale |
2023-03-27 4:41 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
3,656 | $804.26 | $2,940,374 | 1,222,370 (Indirect Direct) |
View |
| 2023-03-23 Sale |
2023-03-27 4:37 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
2,192 | $806.47 | $1,767,782 | 29,180 (Indirect Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $762.5 | $76,250 | 19,147 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $759.89 | $835,879 | 26,491 (Indirect Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:16 pm |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
3,613 | $800 | $2,890,400 | 6,247 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:15 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,571 | $797.86 | $2,849,158 | 15,479 (Indirect Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:15 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
13,189 | $800.08 | $10,552,255 | 1,226,026 (Indirect Direct) |
View |
| 2023-02-07 Sale |
2023-02-08 4:14 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $769.04 | $769,040 | 28,867 (Indirect Direct) |
View |
| 2023-02-03 Sale |
2023-02-07 4:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,021 | $779 | $795,359 | 4,967 (Direct) |
View |
| 2023-02-03 Sale |
2023-02-07 4:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,491 | $776.8 | $1,158,204 | 33,155 (Indirect Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 4:15 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $756.13 | $75,613 | 19,247 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 4:13 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $752.19 | $827,409 | 29,867 (Indirect Direct) |
View |
| 2023-01-27 Sale |
2023-01-30 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1 | $747 | $747 | 19,050 (Indirect Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,070 | $747.14 | $2,293,720 | 19,051 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 4:37 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $726.29 | $72,629 | 21,276 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 4:22 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $721.86 | $794,046 | 30,967 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-15 Gift |
2023-05-17 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
53,807 | $0 | 683,016 (Indirect) |
View |
| 2023-05-09 Gift |
2023-05-10 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
1,326 | $0 | 63,725 (Direct) |
View |
| 2023-04-21 Exercise |
2023-04-24 4:05 pm |
N/A 2026-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,070 | $0 | 12,409 (Direct) |
View |
| 2023-04-21 Exercise |
2023-04-24 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,070 | $520.01 | 12,409 (Direct) |
View |
| 2023-04-03 Gift |
2023-04-05 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
259 | $0 | 467,104 (Indirect) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:00 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 25,391 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $372.46 | 25,391 (Direct) |
View |
| 2023-03-27 Exercise |
2023-03-29 4:07 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,800 | $0 | 52,509 (Direct) |
View |
| 2023-03-27 Exercise |
2023-03-29 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
800 | $381.92 | 52,509 (Direct) |
View |
| 2023-03-27 Exercise |
2023-03-29 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,000 | $378.98 | 52,509 (Direct) |
View |
| 2023-03-27 Tax Withholding |
2023-03-29 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,793 | $825.17 | 52,509 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-27 4:43 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $0 | 3,727 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-27 4:43 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $380.95 | 3,727 (Direct) |
View |
| 2023-03-23 Gift |
2023-03-27 4:42 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
25,000 | $0 | 467,363 (Direct) |
View |
| 2023-03-23 Exercise |
2023-03-27 4:39 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
10,000 | $0 | 33,126 (Direct) |
View |
| 2023-03-23 Exercise |
2023-03-27 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
10,000 | $270.43 | 33,126 (Direct) |
View |
| 2023-03-23 Tax Withholding |
2023-03-27 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
6,742 | $801.59 | 33,126 (Direct) |
View |
| 2023-03-10 Gift |
2023-03-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,006 | $0 | 29,868 (Indirect) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:03 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 26,491 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $372.46 | 26,491 (Direct) |
View |
| 2023-02-22 Exercise |
2023-02-24 4:07 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
42,500 | $0 | 577,363 (Direct) |
View |
| 2023-01-04 Gift |
2023-02-24 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
291 | $0 | 577,363 (Indirect) |
View |
| 2023-02-22 Exercise |
2023-02-24 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
42,500 | $270.43 | 577,363 (Direct) |
View |
| 2023-02-22 Tax Withholding |
2023-02-24 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
29,005 | $750.16 | 577,363 (Direct) |
View |
| 2023-02-12 Tax Withholding |
2023-02-14 4:24 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,276 | $751.78 | 20,941 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:16 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
3,613 | $0 | 6,247 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:16 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
3,613 | $482.68 | 6,247 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:15 pm |
N/A 2026-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,071 | $0 | 15,479 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:15 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,071 | $520.01 | 15,479 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 4:14 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 28,867 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 4:14 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $372.46 | 28,867 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-07 4:10 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $0 | 31,372 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-07 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $270.43 | 31,372 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
3,286 | $774.29 | 31,372 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-07 4:09 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,021 | $0 | 4,967 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-07 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,021 | $380.95 | 4,967 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-07 4:09 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,000 | $0 | 33,155 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-07 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,000 | $381.92 | 33,155 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,248 | $774.29 | 33,155 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 4:13 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 29,867 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 4:13 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $372.46 | 29,867 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-30 4:11 pm |
N/A 2026-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1 | $0 | 19,050 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-30 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1 | $520.01 | 19,050 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-10 4:03 pm |
N/A 2026-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,070 | $0 | 19,051 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,070 | $520.01 | 19,051 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:37 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
2,094 | $0 | 21,276 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 4:22 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 30,967 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 4:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $372.46 | 30,967 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:21 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
2,094 | $0 | 3,176 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:21 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,094 | $0 | 14,838 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:21 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,094 | $0 | 8,176 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:20 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
2,094 | $0 | 3,966 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:19 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
2,094 | $0 | 30,293 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:16 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
2,094 | $0 | 4,363 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:16 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
2,094 | $0 | 4,363 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:15 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
2,094 | $0 | 3,176 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:15 pm |
N/A 2033-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
2,094 | $0 | 3,187 (Direct) |
View |